Take the Zacks Approach to Beat the Markets: Castle Biosciences, Hamilton Insurance & Monster Beverage in Focus

Impact · against what's priced in

Macroeconomic data supports a soft landing narrative, which provides a generally positive backdrop for equities, particularly for growth-oriented names like Castle Biosciences. However, the specific catalyst for CSTL is primarily driven by a Zacks rank upgrade rather than systemic macro shifts.

CSTL+0.60

No priced-in read yet